1.
Kayıkçıoglu E, Findos E. The prognostic immune nutritional index is a predictive biomarker in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide: Prognostic immune nutritional index and prostate adenocancer. The Injector [Internet]. 2022 Nov. 17 [cited 2024 Jul. 17];1(3):106-14. Available from: https://injectormedicaljournal.com/index.php/theinjector/article/view/56